Daito Pharmaceutical Co.,Ltd. [4577.T]

TOKYO, Apr 10 (Pulse News Wire) – Daito Pharmaceutical Co.,Ltd. (4577) has revised its FY2026/5 Full-Year consolidated earnings forecast. FORECAST REVISION SUMMARY: (Unit: ) Revenue Op Profit Ord Profit Net Profit Previous Forecast (A) 52,500 3,000 3,000 2,300 Revised Forecast (B) 51,000 3,300 3,500 2,500 Change (B-A) -1,500 300 500 200 Change (%): Revenue -2.9% | OP +10.0% | OrdP +16.7% | NP +8.7% Prior Year Actual 50,643 2,619 2,705 1,908 KEY CHANGES: - Revenue forecast lowered by +2.9% to 51,000 - Net profit forecast raised by +8.7% to 2,500 - Operating profit forecast raised by +10.0% to 3,300 REASON FOR REVISION: 1 ※ 2

Original Disclosure (PDF)

🟢 Confidence: High AI-translated content.